The rise of drug-resistant bacteria, such as Staphylococcus aureus and its dangerous strain MRSA (Methicillin-Resistant Staphylococcus aureus), has become a serious global health threat. As antibiotics lose effectiveness, researchers are turning to nature for new solutions. A recent review highlights how plants from the genus Erythrina, part of the Fabaceae family, may offer powerful natural compounds to fight these infections.
Erythrina plants are rich in flavonoids, natural compounds long used in traditional medicine for treating infections. This review analyzed studies published between 2000 and 2022, focusing on the antibacterial activities, structural properties, and mechanisms of action of flavonoids isolated from Erythrina species.
The findings revealed that several classes of flavonoids are present, with pterocarpans (31%) emerging as the most active against S. aureus. The review also found that the prenyl functional group plays a key role in boosting antibacterial strength—adding more prenyl groups enhances effectiveness, while modifications can reduce it.
These flavonoids work in different ways to combat bacteria:
- Suppressing nucleic acid synthesis,
- Disrupting cell membrane function, and
- Modulating energy metabolism.
One standout compound, 3,9-dihydroxy-10-γ,γ-dimethylallyl-6a,11a-dehydropterocarpan, showed strong activity against MRSA by blocking nucleic acid synthesis. Meanwhile, common flavonoids like genistein, daidzein, apigenin, and luteolin were found to inhibit ATP synthase, weakening bacterial survival.
This scientific evidence supports the traditional use of Erythrina plants in treating infections and points to their potential role in developing new antibacterial therapies. Importantly, it also connects with Sustainable Development Goal (SDG) 3: Good Health and Well-being, which calls for ensuring healthy lives and combating major global health risks like antibiotic resistance.
By revisiting nature’s pharmacy, researchers are opening the door to alternative solutions that could one day help overcome the challenge of superbugs and safeguard public health.
#UnpadResearch #Antibacterial #GoodHealth
Link to the paper: https://pubmed.ncbi.nlm.nih.gov/39811340/
35/Kim/2025
